NDR Medical Technology develops AI-empowered interventional robots, including the ANT-C and ANT-X needle targeting systems.
Founded in 2015 and based in Singapore, NDR Medical Technology Pte Ltd develops AI-empowered interventional robotics that improve needle placement in minimally invasive procedures. Its Automated Needle Targeting systems, ANT-C and ANT-X, are used in interventional radiology and urology and sold to hospitals in markets such as Singapore and Japan. Revenue comes from B2B sales of robotic systems plus maintenance and training. The company raised USD 0.37 mn in a Series B round from ST Engineering Ventures on March 24, 2021. CEO Alan Goh leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in